vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and New Fortress Energy Inc. (NFE). Click either name above to swap in a different company.
New Fortress Energy Inc. is the larger business by last-quarter revenue ($326.2M vs $168.4M, roughly 1.9× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -7.0%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs -26.8%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
New Fortress Energy Inc. is a global energy infrastructure firm developing, owning and operating LNG import/export terminals, natural gas supply networks and low-carbon projects. It serves utility, industrial and public sector clients across the Americas and Caribbean, delivering affordable, lower-emission energy resources.
ESPR vs NFE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $326.2M |
| Net Profit | — | $-847.1M |
| Gross Margin | — | 35.5% |
| Operating Margin | 50.6% | -193.0% |
| Net Margin | — | -259.7% |
| Revenue YoY | 143.7% | -7.0% |
| Net Profit YoY | — | -277.4% |
| EPS (diluted) | $0.32 | $-3.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $326.2M | ||
| Q3 25 | $87.3M | $240.3M | ||
| Q2 25 | $82.4M | $228.1M | ||
| Q1 25 | $65.0M | $384.9M | ||
| Q4 24 | $69.1M | $350.7M | ||
| Q3 24 | $51.6M | $446.0M | ||
| Q2 24 | $73.8M | $291.2M | ||
| Q1 24 | $137.7M | $609.5M |
| Q4 25 | — | $-847.1M | ||
| Q3 25 | $-31.3M | $-263.0M | ||
| Q2 25 | $-12.7M | $-546.5M | ||
| Q1 25 | $-40.5M | $-175.4M | ||
| Q4 24 | — | $-224.4M | ||
| Q3 24 | $-29.5M | $9.3M | ||
| Q2 24 | $-61.9M | $-88.9M | ||
| Q1 24 | $61.0M | $54.1M |
| Q4 25 | — | 35.5% | ||
| Q3 25 | — | 18.1% | ||
| Q2 25 | — | 8.4% | ||
| Q1 25 | — | 21.4% | ||
| Q4 24 | — | 17.6% | ||
| Q3 24 | — | 27.1% | ||
| Q2 24 | — | 23.8% | ||
| Q1 24 | — | 62.4% |
| Q4 25 | 50.6% | -193.0% | ||
| Q3 25 | -11.4% | -37.4% | ||
| Q2 25 | 8.6% | -170.3% | ||
| Q1 25 | -34.0% | -3.3% | ||
| Q4 24 | -6.4% | 65.0% | ||
| Q3 24 | -31.0% | 17.8% | ||
| Q2 24 | 3.5% | 12.3% | ||
| Q1 24 | 52.5% | 30.4% |
| Q4 25 | — | -259.7% | ||
| Q3 25 | -35.9% | -109.4% | ||
| Q2 25 | -15.4% | -239.6% | ||
| Q1 25 | -62.2% | -45.6% | ||
| Q4 24 | — | -64.0% | ||
| Q3 24 | -57.2% | 2.1% | ||
| Q2 24 | -83.9% | -30.5% | ||
| Q1 24 | 44.3% | 8.9% |
| Q4 25 | $0.32 | $-3.03 | ||
| Q3 25 | $-0.16 | $-0.96 | ||
| Q2 25 | $-0.06 | $-1.99 | ||
| Q1 25 | $-0.21 | $-0.65 | ||
| Q4 24 | $-0.14 | $-1.10 | ||
| Q3 24 | $-0.15 | $0.03 | ||
| Q2 24 | $-0.33 | $-0.42 | ||
| Q1 24 | $0.34 | $0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $226.5M |
| Total DebtLower is stronger | — | $8.2B |
| Stockholders' EquityBook value | $-302.0M | $182.6M |
| Total Assets | $465.9M | $10.6B |
| Debt / EquityLower = less leverage | — | 44.78× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $226.5M | ||
| Q3 25 | $92.4M | $145.2M | ||
| Q2 25 | $86.1M | $551.1M | ||
| Q1 25 | $114.6M | $447.9M | ||
| Q4 24 | $144.8M | $492.9M | ||
| Q3 24 | $144.7M | $90.8M | ||
| Q2 24 | $189.3M | $133.0M | ||
| Q1 24 | $226.6M | $143.5M |
| Q4 25 | — | $8.2B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $8.9B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-302.0M | $182.6M | ||
| Q3 25 | $-451.4M | $1.1B | ||
| Q2 25 | $-433.5M | $1.3B | ||
| Q1 25 | $-426.2M | $1.8B | ||
| Q4 24 | $-388.7M | $1.9B | ||
| Q3 24 | $-370.2M | $1.6B | ||
| Q2 24 | $-344.2M | $1.6B | ||
| Q1 24 | $-294.3M | $1.7B |
| Q4 25 | $465.9M | $10.6B | ||
| Q3 25 | $364.0M | $12.0B | ||
| Q2 25 | $347.1M | $12.0B | ||
| Q1 25 | $324.0M | $13.1B | ||
| Q4 24 | $343.8M | $12.9B | ||
| Q3 24 | $314.1M | $12.0B | ||
| Q2 24 | $352.3M | $11.4B | ||
| Q1 24 | $373.1M | $10.9B |
| Q4 25 | — | 44.78× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.74× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $-76.2M |
| Free Cash FlowOCF − Capex | — | $-134.8M |
| FCF MarginFCF / Revenue | — | -41.3% |
| Capex IntensityCapex / Revenue | 0.0% | 18.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.4B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $-76.2M | ||
| Q3 25 | $-4.3M | $-171.0M | ||
| Q2 25 | $-31.4M | $-329.0M | ||
| Q1 25 | $-22.6M | $-7.2M | ||
| Q4 24 | $-35.0M | $445.3M | ||
| Q3 24 | $-35.3M | $-20.0M | ||
| Q2 24 | $-7.2M | $113.9M | ||
| Q1 24 | $53.8M | $63.0M |
| Q4 25 | — | $-134.8M | ||
| Q3 25 | — | $-231.6M | ||
| Q2 25 | — | $-726.7M | ||
| Q1 25 | — | $-262.3M | ||
| Q4 24 | — | $-210.3M | ||
| Q3 24 | $-35.5M | $-367.0M | ||
| Q2 24 | $-7.3M | $-493.2M | ||
| Q1 24 | $53.8M | $-457.9M |
| Q4 25 | — | -41.3% | ||
| Q3 25 | — | -96.4% | ||
| Q2 25 | — | -318.6% | ||
| Q1 25 | — | -68.2% | ||
| Q4 24 | — | -60.0% | ||
| Q3 24 | -68.7% | -82.3% | ||
| Q2 24 | -9.9% | -169.3% | ||
| Q1 24 | 39.0% | -75.1% |
| Q4 25 | 0.0% | 18.0% | ||
| Q3 25 | 0.0% | 25.2% | ||
| Q2 25 | 0.0% | 174.4% | ||
| Q1 25 | 0.0% | 66.3% | ||
| Q4 24 | 0.0% | 187.0% | ||
| Q3 24 | 0.3% | 77.8% | ||
| Q2 24 | 0.1% | 208.4% | ||
| Q1 24 | 0.1% | 85.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -2.15× | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | 1.16× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
NFE
Segment breakdown not available.
